Related references
Note: Only part of the references are listed.Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience
Shimin Jasmine Chung et al.
LEUKEMIA & LYMPHOMA (2019)
Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index
Yasufumi Kawasaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
Matthew Ziegler et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis
Weerapat Owattanapanich et al.
HEMATOLOGY (2019)
Impact of fluoroquinolone prophylaxis on documented infections in patients with febrile neutropenia
Daniel J. Przybylski et al.
INFECTIOUS DISEASES (2018)
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Randy A. Taplitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia
Joshua Wolf et al.
CLINICAL INFECTIOUS DISEASES (2017)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Prevention and Treatment of Cancer-Related Infections, Version 2.2016
Lindsey Robert Baden et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis
Antonia Bainschab et al.
LEUKEMIA RESEARCH (2016)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
Impact of Duration of Neutropenia and Lymphopenia on AML Patients Undergoing Induction Chemotherapy
Madiha Iqbal et al.
BLOOD (2016)
The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought
Brad Spellberg et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Charlie G. Buffie et al.
NATURE (2015)
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A. Buckley et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Joana Sousa et al.
CURRENT DRUG SAFETY (2014)
Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli
Lalit Saini et al.
BMC INFECTIOUS DISEASES (2013)
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
C. Gudiol et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Perils of Quinolone Exposure in Cancer Patients Breakthrough Bacteremia With Multidrug-Resistant Organisms
Gopi Rangaraj et al.
CANCER (2010)
Escherichia coli resistance to quinolones at a comprehensive cancer center
Coralia N. Mihu et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Antibiotic prophylaxis in neutropenic patients - New evidence, practical decisions
Leonard Leibovici et al.
CANCER (2006)
Immunological characterization and antibacterial function of persisting Granulocytes in leukemic patients receiving pulse cytosine arabinoside-consolidation chemotherapy on days 1, 3, and 5
MT Krauth et al.
JOURNAL OF IMMUNOLOGY (2006)
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
G Bucaneve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
M Cullen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
A. Gafter-Gvili et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Share Paper
